You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 133 No. 2, February 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  OFF-CENTER FOLD
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

An Enlarging Papulosquamous Plaque on the Buttock

José M. Marcaró, Jr, MD; Encarnación Martín-Ortega, MD; Francesc Bosch, MD; Alvaro Urbano-lzpizua, MD

Arch Dermatol. 1997;133(2):235-236.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

REPORT OF A CASE

A 41-year-old white man presented with a pruritic plaque on his buttock that he had first noticed 1 month earlier. Physical examination revealed a 20x10-cm erythematous plaque that involved the posterior aspect of the left thigh and buttock (Figure 1). He had been diagnosed as having adult T-cell leukemia/lymphoma (ATLL) 2 years earlier, when he was evaluated for a casually detected lymphocytosis with 30% atypical circulating lymphocytes. Antibodies to the p24 protein of human T-cell lymphotropic virus type I (HTLV-I) and monoclonal integration of the viral DNA into the neoplastic lymphoid cells were both demonstrated at that time. Chemotherapy was initiated when the patient developed an increasing leukocytosis with symptomatic hypercalcemia. Nine months after his initial presentation, he achieved complete remission after being treated with combination chemotherapy consisting of 6 cycles of cyclophosphamide, doxorubicin (hydroxydaunomycin), vincristine sulfate (Oncovin), and prednisone (CHOP) and pentostatin (deoxycoformycin). He . . . [Full Text PDF of this Article]


Author Affiliations

Hospital Clinic, Barcelona, Spain



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.